Table 4 Multivariate Cox regression for DFS in the retrospective study.

From: Optimal pathological response indicated better long-term outcome among patients with stage IB2 to IIB cervical cancer submitted to neoadjuvant chemotherapy

Variables

Retrospective study

B

HR(95% CI)

P

Pathological response

 OPR

 

1

 

Non-OPR

0.96

2.61(1.06,6.45)

0.037

FIGO stage

 IB2

 

1

 

 IIA

0.60

1.81(1.19,2.78)

0.006

 IIB

0.44

1.55(1.03,2.34)

0.038

Grade

 G1

 

1

 

 G2

0.50

1.61(0.77,3.38)

0.20

 G3

1.11

3.05(1.46,6.34)

0.003

 Undetermined

0.22

1.24(0.56,2.75)

0.60

Cell type

 Squamous

 

1

 

Non-squamous

0.56

1.76(1.18,2.61)

0.005

Lymph node metastasis

 Negative

 

1

 

 Positive

0.58

1.78(1.30,2.42)

<0.001

  1. FIGO, International Federation of Gynecology and Obstetrics; DFS, disease free survival.
Back to article page